Atlas Trials

Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19

Clinical trial NCT04467047 · UNKNOWN

Trial details

NCT number
NCT04467047
Sponsor
Hospital de Clinicas de Porto Alegre
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19Sars-CoV2
Start date
2020-07-25
Primary completion
2020-10-30
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.